View in EDS

Impact of Antihypertensive Treatment on Outcomes of Adjuvant Bevacizumab for Ovarian Cancer (IATRO), Results from a Nationwide Emulated Clinical Trial.

Saved in:
Bibliographic Details
Title: Impact of Antihypertensive Treatment on Outcomes of Adjuvant Bevacizumab for Ovarian Cancer (IATRO), Results from a Nationwide Emulated Clinical Trial.
Authors: Jochum F; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Institut Curie, Paris, France.; Department of Gynaecology, Strasbourg University Hospital, Strasbourg, France., Dumas É; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Institut Curie, Paris, France.; Institute of Mathematics, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland., Salem JE; Clinical Investigation Center (CIC-1901) INSERM, Department of Pharmacology, Pitié-Salpêtrière Hospital, Sorbonne Université, Paris, France., Ederhy S; Cardiology Department, Saint-Antoine University Hospital, AP-HP, Paris, France., Hamy AS; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Institut Curie, Paris, France.; Department of Medical Oncology, Institut Curie, Paris, France., Lecointre L; Department of Gynaecology, Strasbourg University Hospital, Strasbourg, France., Laas E; Department of Breast and Gynaecological Surgery, Institut Curie, Paris, France., Reyal F; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Institut Curie, Paris, France.; Department of Breast and Gynaecological Surgery, Institut Curie, Paris, France.; Department of Surgical Oncology, Institut Godinot, Reims, France., Lecuru F; Department of Breast and Gynaecological Surgery, Institut Curie, Paris, France., Akladios C; Department of Gynaecology, Strasbourg University Hospital, Strasbourg, France., Gougis P; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Institut Curie, Paris, France.; Clinical Investigation Center (CIC-1901) INSERM, Department of Pharmacology, Pitié-Salpêtrière Hospital, Sorbonne Université, Paris, France.; Department of Medical Oncology, Sorbonne Université, Institut Universitaire du Cancer, Pitié-Salpêtrière Hospital, Paris, France.
Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2026 Jan; Vol. 119 (1), pp. 198-207. Date of Electronic Publication: 2025 Sep 26.
Publication Type: Journal Article; Comparative Study
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40999916
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Impact of Antihypertensive Treatment on Outcomes of Adjuvant Bevacizumab for Ovarian Cancer (IATRO), Results from a Nationwide Emulated Clinical Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Jochum+F%22">Jochum F</searchLink>; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Institut Curie, Paris, France.; Department of Gynaecology, Strasbourg University Hospital, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Dumas+É%22">Dumas É</searchLink>; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Institut Curie, Paris, France.; Institute of Mathematics, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Salem+JE%22">Salem JE</searchLink>; Clinical Investigation Center (CIC-1901) INSERM, Department of Pharmacology, Pitié-Salpêtrière Hospital, Sorbonne Université, Paris, France.<br /><searchLink fieldCode="AU" term="%22Ederhy+S%22">Ederhy S</searchLink>; Cardiology Department, Saint-Antoine University Hospital, AP-HP, Paris, France.<br /><searchLink fieldCode="AU" term="%22Hamy+AS%22">Hamy AS</searchLink>; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Institut Curie, Paris, France.; Department of Medical Oncology, Institut Curie, Paris, France.<br /><searchLink fieldCode="AU" term="%22Lecointre+L%22">Lecointre L</searchLink>; Department of Gynaecology, Strasbourg University Hospital, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Laas+E%22">Laas E</searchLink>; Department of Breast and Gynaecological Surgery, Institut Curie, Paris, France.<br /><searchLink fieldCode="AU" term="%22Reyal+F%22">Reyal F</searchLink>; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Institut Curie, Paris, France.; Department of Breast and Gynaecological Surgery, Institut Curie, Paris, France.; Department of Surgical Oncology, Institut Godinot, Reims, France.<br /><searchLink fieldCode="AU" term="%22Lecuru+F%22">Lecuru F</searchLink>; Department of Breast and Gynaecological Surgery, Institut Curie, Paris, France.<br /><searchLink fieldCode="AU" term="%22Akladios+C%22">Akladios C</searchLink>; Department of Gynaecology, Strasbourg University Hospital, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Gougis+P%22">Gougis P</searchLink>; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Institut Curie, Paris, France.; Clinical Investigation Center (CIC-1901) INSERM, Department of Pharmacology, Pitié-Salpêtrière Hospital, Sorbonne Université, Paris, France.; Department of Medical Oncology, Sorbonne Université, Institut Universitaire du Cancer, Pitié-Salpêtrière Hospital, Paris, France.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220372741%22">Clinical pharmacology and therapeutics</searchLink> [Clin Pharmacol Ther] 2026 Jan; Vol. 119 (1), pp. 198-207. <i>Date of Electronic Publication: </i>2025 Sep 26.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Comparative Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0372741 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-6535 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200099236%22">00099236 </searchLink><i>NLM ISO Abbreviation: </i>Clin Pharmacol Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40999916
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/cpt.70067
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 198
    Titles:
      – TitleFull: Impact of Antihypertensive Treatment on Outcomes of Adjuvant Bevacizumab for Ovarian Cancer (IATRO), Results from a Nationwide Emulated Clinical Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Jochum F
      – PersonEntity:
          Name:
            NameFull: Dumas É
      – PersonEntity:
          Name:
            NameFull: Salem JE
      – PersonEntity:
          Name:
            NameFull: Ederhy S
      – PersonEntity:
          Name:
            NameFull: Hamy AS
      – PersonEntity:
          Name:
            NameFull: Lecointre L
      – PersonEntity:
          Name:
            NameFull: Laas E
      – PersonEntity:
          Name:
            NameFull: Reyal F
      – PersonEntity:
          Name:
            NameFull: Lecuru F
      – PersonEntity:
          Name:
            NameFull: Akladios C
      – PersonEntity:
          Name:
            NameFull: Gougis P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2026 Jan
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1532-6535
          Numbering:
            – Type: volume
              Value: 119
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Clinical pharmacology and therapeutics
              Type: main
ResultId 1